Improved Management of the Advanced Nonseminomatous Testis Cancer
With the VAB-6 program about 90% (54/59) of patients with stage III and bulky stage II disease achieved complete remission and eighty percent remain free of disease. Patients with minimal metastatic disease can usually be treated successfully with chemotherapy alone, while patients with advanced di...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Instituto Nacional de Câncer (INCA)
2023-08-01
|
| Series: | Revista Brasileira de Cancerologia |
| Subjects: | |
| Online Access: | https://rbc.inca.gov.br/index.php/revista/article/view/3379 |